An activatable theranostic for targeted cancer therapy and imaging.
about
Theranostic nanoparticlesNovel delivery approaches for cancer therapeutics.A pillararene-based ternary drug-delivery system with photocontrolled anticancer drug release.Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.Cu-Au alloy nanostructures coated with aptamers: a simple, stable and highly effective platform for in vivo cancer theranostics.Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging.Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics.Smart Probe for Tracing Cancer Therapy: Selective Cancer Cell Detection, Image-Guided Ablation, and Prediction of Therapeutic Response In Situ.Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.Molecular design and synthesis of a pH independent and cell permeant fluorescent dye and its applications.NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery.Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs.Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs.Stimuli-responsive multifunctional glyconanoparticle platforms for targeted drug delivery and cancer cell imagingImaging of formaldehyde in plants with a ratiometric fluorescent probe.Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics.An arylboronate locked fluorescent probe for hypochlorite.Highly efficient photosensitizers with aggregation-induced emission characteristics obtained through precise molecular design.A biotinylated piperazine-rhodol derivative: a 'turn-on' probe for nitroreductase triggered hypoxia imaging.Intracellular Dual Fluorescent Lightup Bioprobes for Image-Guided Photodynamic Cancer Therapy.A tumor-specific and mitochondria-targeted fluorescent probe for real-time sensing of hypochlorite in living cells.Redox-responsive xanthene-coumarin-chlorambucil-based FRET-guided theranostics for "activatable" combination therapy with real-time monitoring.An oral redox-sensitive self-immolating prodrug strategy.Development of a Two-Photon Fluorescent Probe for Imaging of Endogenous Formaldehyde in Living Tissues.Binding-responsive catalysis of Taq DNA polymerase for the sensitive and selective detection of cell-surface proteins.A biotin-conjugated glutathione-responsive FRET-based fluorescent probe with a ferrocenyl BODIPY as the dark quencher.A mitochondrial-targeted prodrug for NIR imaging guided and synergetic NIR photodynamic-chemo cancer therapy.Discrimination between streptavidin and avidin with fluorescent affinity-based probes.Redox-responsive degradable honeycomb manganese oxide nanostructures as effective nanocarriers for intracellular glutathione-triggered drug release.Advances in targeting the folate receptor in the treatment/imaging of cancers.The development of a novel AND logic based fluorescence probe for the detection of peroxynitrite and GSH.Rational design of biotinylated probes: fluorescent turn-on detection of (strept)avidin and bioimaging in cancer cells
P2860
Q28650348-6F988CD2-986B-4CAF-884C-786757BBC2F8Q30368171-33E35135-8D75-4799-AB26-ADB53E9FBF91Q30860444-C450663B-D3CD-41C3-A004-D98225CDA5E8Q35762630-DE71EA13-137C-493D-9C3F-1DF949B3E510Q35888517-4EB35B69-9596-4517-9B05-9D7744CB8E6EQ38539464-AF52AF9E-29AF-4C01-8135-3F495397BED5Q38728260-9B287C8D-B271-4D1B-88C0-8A4804772C14Q38782458-A48D3E72-5367-4FEF-B8AD-521C5E3CB5F0Q38859246-38B27249-F481-4E40-AA40-4975190FC6DEQ38859857-0AFF87A6-FF48-40DA-877E-1E6C0A63F2E3Q38870923-68EBFB42-0281-4448-B4F3-B9DAF952E5AFQ38872474-F3976489-0CFD-4766-9A48-B99A141383ADQ38873039-82926B01-E8A5-47AE-AEA0-06877A878A95Q38890277-3F3301A5-A456-4CCF-BC57-246D3EAE3EA4Q38946777-DFEFDA16-03FF-4BC6-8EBD-25607314D6ACQ38950336-4A80AC66-40B1-4DC9-B725-B27199E6AB08Q38964979-55168FEC-8F60-4568-9115-FF2DD782C9B6Q39216032-E9C735C5-D987-404F-9AB2-94B887619EFFQ41141393-15544F70-511D-414E-A52D-7240C104E289Q42263510-DC8130D1-82AC-4250-B769-4414A2C9547EQ42367186-53B88296-C1E1-40CA-86C7-AFAC4E2EF007Q46277986-9C821D04-A0C9-4918-9085-740D7A4A58B7Q46360319-0BC96D51-5972-41DD-B392-DDBB8DDA043AQ47903423-697679FE-D7E5-4B73-B53A-FCEAF1085D7DQ48157789-F103AB9A-6DD2-4EC3-80A8-5A401D3807F6Q50200887-9238C4C1-9168-4AFF-A6EC-697648212F2CQ50202617-3008F64C-6C24-49BB-A1EA-C158EFD80A75Q50516134-86F6B90E-11C5-4B70-ACA5-B40BCC656190Q51004337-94901C07-248D-4620-9B06-10E6E953222AQ51535884-0755B339-FAE4-4485-81F9-2F8AA929FBE6Q51582254-7449FBD7-1043-4B0E-A94E-19FC78CEFE1BQ51735890-75143A1A-019F-4C7A-A507-CC0967DA9519Q52606053-60B7DEE3-92E1-429A-A70E-EA010AF5B483Q53232104-38709A2D-4C1D-4E41-B087-0E93B213CB49Q53386285-014D484D-FE69-43D0-A8A5-4728B8FE208AQ55315165-0DEFEEAE-F9CB-4624-84FE-F8637523BB84Q55381993-359004CE-FD28-43B2-A0B9-391784B71932Q57183264-4F0AA1E1-A4D5-42F0-A73E-99DECD064A81
P2860
An activatable theranostic for targeted cancer therapy and imaging.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
An activatable theranostic for targeted cancer therapy and imaging.
@en
An activatable theranostic for targeted cancer therapy and imaging.
@nl
type
label
An activatable theranostic for targeted cancer therapy and imaging.
@en
An activatable theranostic for targeted cancer therapy and imaging.
@nl
prefLabel
An activatable theranostic for targeted cancer therapy and imaging.
@en
An activatable theranostic for targeted cancer therapy and imaging.
@nl
P2093
P2860
P356
P1476
An activatable theranostic for targeted cancer therapy and imaging.
@en
P2093
Eun-Joong Kim
Hyunseung Lee
Jonathan L Sessler
Jong Seung Kim
Kwan Soo Hong
Sukhendu Maiti
P2860
P304
P356
10.1002/ANIE.201311133
P407
P577
2014-03-18T00:00:00Z